Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma

Clinical trial NCT01913691 · WITHDRAWN

Trial details

NCT number: NCT01913691
Sponsor: National Cancer Institute (NCI)
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Merkel Cell Carcinoma

Start date: 2013-07-09
Primary completion: 2014-02-03
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.